The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

January 25, 2023


DEA confirms end of DATA waiver program
In a January 12 letter to registrants, the DEA confirmed the end of the DATA waiver program for prescribers who wish to use buprenorphine to treat opioid use disorder, the result of the passage of the Consolidated Appropriations Act, and, more specifically, the Mainstreaming Addiction Treatment Act contained within. The MAT amended 21 U.S.C. §823 to eliminate the DATA waiver program, and to establish training requirements for DEA registrants wishing to prescribe controlled substances. The DEA letter explained that all prescribers authorized to prescribe Schedule III controlled substances may now use buprenorphine to treat opioid use disorder, without any caps on the number of patients treated. Pharmacists may immediately dispense prescriptions for buprenorphine medication-assisted treatment from any authorized prescriber and DEA numbers including “X” are no longer required. The DEA indicated that training requirements (8 hours of CME) will become effective June 21, 2023. DEA and SAMSHA are actively working to prepare further guidances for registrants. [USDOJ, DEA. DEA announces important changes in registration requirements. 2023 Jan 12;]